However, our research indicates that simultaneous measurement of sST2 and Gal-3 with the CTR can facilitate the early identification of CKD patients at an increased risk of cardiac alterations, even before such changes become detectable through standard imaging techniques. The gene discussed is LGALS3; the disease is chronic kidney disease.